Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial ctsu/Calgb90601
A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma.
Type:
Treatment
Phase:
Phase III
Status:
Not Open (Closed)
Treatments:
Anti-Angiogenesis, Chemotherapy: Systemic
Randomized:
Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
James Hu, M.D.
Other Trial Staff:
Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Carol Jones, R.N., Honorina Enright, D.M., Laurie De Oliveira, D.M., Yvette Viverette, R.N., Torsten Fischer, R.N.
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.